10x Insights
Loading account…
Companies / Healthcare / LifeMD, Inc.
LFMD

LifeMD, Inc.

HealthcareHealth Services
Ticker LFMDNEW YORK, NYFiscal year ends DecemberBook value per share $0.17Diluted shares 47.6M

LifeMD, Inc. (NASDAQ: LFMD) operates as a patient-centric, direct-to-patient healthcare company providing virtual medical care and pharmacy services through a vertically integrated platform. The company's website is located at https://ir.lifemd.com/. From the company’s description.

Fiscal year 2025 · ends 12-31Changes are against fiscal 2024The amber dot is the latest twelve months, to 2026-06-30
Sales & profitability
$194.06M
−8.7% year over year
Last 12 mo $163.58M
-3.95%
+3.6 percentage points
Last 12 mo -15.51%
$-10.23M
+45.4% year over year
Last 12 mo $-26.54M
61.99%
−282.2 percentage points
Last 12 mo -11.45%
Cash & financing
$8.28M
−52.7% year over year
Last 12 mo $-9.91M
$-1.24M
−120.7% year over year
Last 12 mo $-16.55M
0.00
Was -3.34× a year earlier
45.1M
+9.5% year over year
Last 12 mo 47.6M

Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.

What LifeMD, Inc. does

In the company’s own words

LifeMD, Inc. (NASDAQ: LFMD) operates as a patient-centric, direct-to-patient healthcare company providing virtual medical care and pharmacy services through a vertically integrated platform. The company's website is located at https://ir.lifemd.com/.

LifeMD serves approximately 328,000 active patient subscribers as of December 31, 2025, having cumulatively served approximately 1.387 million patients and customers since inception. The company operates three primary consumer healthcare brands: LifeMD, its flagship virtual primary care and specialty platform; Rex MD, focused on men's health conditions; and ShapiroMD, specializing in hair loss treatment. Approximately 95 percent of total revenue is derived from recurring subscriptions.

The company's integrated platform combines proprietary technology, affiliated clinical services, pharmacy infrastructure, and artificial intelligence-enabled operational systems. Core offerings include virtual primary care, weight management programs featuring GLP-1 medications and non-GLP-1 treatment options, women's health services addressing perimenopause and menopause, behavioral health services, and testosterone replacement therapy. The company operates a wholly-owned commercial pharmacy facility in Lancaster, Pennsylvania, capable of filling up to 5,000 daily prescriptions and featuring advanced non-sterile compounding capabilities for oral and topical medications.

LifeMD maintains an affiliated 50-state medical provider network composed of licensed physicians and nurse practitioners, with a significant portion consisting of full-time providers dedicated to the platform. The company operates an internal patient care center in Greenville, South Carolina, staffed by approximately 119 employees providing care coordination and customer support functions. As of December 31, 2025, the company employed 389 total employees, comprising 347 full-time, 5 part-time, and 37 temporary employees.

The company has established partnerships with major pharmaceutical manufacturers including Novo Nordisk and Eli Lilly, integrating streamlined access pathways for branded obesity and diabetes therapies. In June 2024, LifeMD began accepting commercial and government health insurance, with network coverage expanding to approximately 112 million lives, including approximately 30 million Medicare Fee-for-Service beneficiaries. The company divested its majority ownership interest in WorkSimpli Software LLC in November 2025, positioning itself as a pure-play healthcare company.

Company details
Sector
Healthcare
Industry
Health Services
Headquarters
NEW YORK, NY
Fiscal year end
December
CIK
948320
SIC
8011

Financial performance, year by year

Fiscal 2013–2025 · USD
$-88.70M$-6.57M$75.56M$157.70M$239.83M2013201420152016201720182019202020212022202320242025Last 12 moLast 12 monthsLast 12 months

The full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.

Ownership

Who owns LifeMD, Inc. — and what changed

Funds as of 2026Q2 · superinvestors as of 2026-06-30

109
funds hold it
0 of 35
superinvestors hold it
$32.72M
held by funds, at market
16.0%
of shares held by funds

Largest fund holders · LifeMD, Inc.’s weight in each

VANGUARD TOTAL STOCK MARKET INDEX FUND
VTI · VANGUARD INDEX FUNDS
0.00%of fund net assets
iShares Russell 2000 ETF
IWM · iShares Trust
0.01%of fund net assets
Bridge Builder Small/Mid Cap Growth Fund
BBGSX · Bridge Builder Trust
0.03%of fund net assets
0.08%of fund net assets
Federated Hermes MDT Small Cap Core Fund
QASCX · Federated Hermes MDT Series
0.12%of fund net assets

Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.

Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.

Could not be determined for this company: bond issues.

Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.

Connected research

Put this business in context.

Compare this company with peers, find it in your funds and follow its financial history with your connected AI:

  • “How do LifeMD, Inc. and its peers compare on margins and cash generation over ten years?”
  • “Where did five years of LifeMD, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
  • “What changed in LifeMD, Inc.'s last four quarterly filings that the numbers alone won't show?”
See how it works →All research tools with a subscription. Use your own AI account.